Xtant Medical Holdings (XTNT) Cash from Financing Activities (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Cash from Financing Activities data on file, last reported at -$5.8 million in Q3 2025.

• On a quarterly basis, Cash from Financing Activities fell 208.6% year-over-year to -$5.8 million in Q3 2025; TTM through Sep 2025 was -$6.9 million, a 139.89% decrease from a year earlier, with the FY2024 full-year figure at $16.1 million, down 18.37% from the prior year.
• Cash from Financing Activities for Q3 2025 stood at -$5.8 million, down from $662000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for XTNT reached as high as $18.1 million in Q1 2021 and fell as low as -$5.8 million in Q3 2025.
• Historically, Cash from Financing Activities has averaged $3.0 million across 5 years, with a median of $662000.0 in 2025.
• On a YoY basis, Cash from Financing Activities climbed as much as 53311.76% in 2021 and fell as far as 1515.0% in 2021.
• Year by year, Cash from Financing Activities stood at -$55000.0 in 2021, then jumped by 10307.27% to $5.6 million in 2022, then plunged by 94.21% to $325000.0 in 2023, then tumbled by 362.77% to -$854000.0 in 2024, then tumbled by 575.76% to -$5.8 million in 2025.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$5.8 million in Q3 2025, $662000.0 in Q2 2025, and -$919000.0 in Q1 2025.